CCHD PulseOx screening vs PneumoRecs VaxAdvisor

In 2011, pulse oximetry screening was recommended to improve the detection of critical congenital heart defects in newborns. This application was developed by Children’s Healthcare of Atlanta to aid healthcare professionals in implementing pulse oximetry screening in the newborn nursery. The algorithm is endorsed by the American Academy of Pediatrics and the American Heart Association.

This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.